<DOC>
	<DOC>NCT02231944</DOC>
	<brief_summary>To compare the first and second recovery assessments on Replenine®-VF and to evaluate recovery of different batches if patients changed batches during the study. To evaluate Replenine®-VF in terms of long-term clinical efficacy, tolerance and safety</brief_summary>
	<brief_title>An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<criteria>Previously treated patients At least 12 years of age Severe Haemophilia B and without inhibitor to factor IX</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>